Medicine and Dentistry
Androgen
33%
Benign Tumor
27%
Bladder
33%
Bladder Injury
33%
Bladder Tumor
33%
Cancer Research
33%
Cohort Analysis
33%
COVID-19
33%
Cryoablation
33%
Cryotherapy
33%
Diagnosis
33%
Dosimetry
33%
Endourology
33%
Enucleation
100%
Germ Cell Cancer
33%
Holmium
33%
Infection
33%
Kidney Arteriovenous Fistula
33%
Kidney Injury
33%
Kidney Stone
33%
Laser Surgery
22%
Learning Curve
33%
Magnetic Resonance Imaging
61%
Malignant Neoplasm
38%
Meta-Analysis
44%
Nurse
33%
Obstruction
73%
Oxidative Stress
33%
Pediatrics
33%
Penis Cancer
66%
Prostate Cancer
33%
Prostate Surgery
33%
Prostatectomy
44%
Quality of Life
40%
Randomized Controlled Trial
36%
Retreatment
33%
Sex Hormone
37%
Spermiogenesis
33%
Surgeon
88%
Surgery
64%
Surgery
33%
Surgical Technique
38%
Systematic Review
33%
Testis Cancer
33%
Thulium
55%
Traffic Accident
33%
Transurethral Resection
80%
Urinary Diversion
33%
Urinary Tract Pathology
33%
Urothelium
33%
Nursing and Health Professions
Art Therapy
6%
Bladder Tumor
33%
Cancer Surgery
33%
Cognitive Defect
6%
Collaborative Research
6%
Compliance
6%
Counseling
6%
Cystectomy
6%
Diagnosis
26%
Health Status
6%
Ileal Conduit
6%
Interrater Reliability
6%
Kidney Stone
33%
Life Expectancy
13%
Medical Device
33%
Muscle Invasive Bladder Cancer
6%
Neoadjuvant Chemotherapy
6%
Operation Duration
6%
Outpatient Department
11%
Pathologist
33%
Perioperative
6%
Physical Disease
6%
Practice Guideline
33%
Preoperative Evaluation
6%
Prostate Size
16%
Prostate Volume
33%
Quality of Life
6%
Robotics
33%
Treatment Outcome
6%
Turnaround Time
6%
Ureter Stent
6%
Ureterostomy
6%
Urinary Diversion
33%
Pharmacology, Toxicology and Pharmaceutical Science
Abiraterone
16%
Androgen
33%
Bladder Stone
33%
Cancer Specific Survival
8%
Chemotherapy
20%
Darolutamide
16%
Disease
16%
Diverticulosis
33%
Docetaxel
12%
Erectile Dysfunction
7%
Infection
33%
Obstruction
33%
Overall Survival
8%
Penis Cancer
33%
Peroperative Complication
8%
Prostate Cancer
66%
Prostate Hypertrophy
33%
Recurrent Disease
16%
Survival Rate
8%
Syndrome
33%
Tolerability
8%
